ArticleLeukemia2025
Patterns and variations of copy number alterations in acute myeloid leukemia: insights from the LeukAtlas database.
Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An externally validated lactylation-associated prognostic signature for overall survival prediction in lung adenocarcinoma identifiesTranslational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Recent pan-cancer analysis revealed the global pattern and potential aetiologies of copy number variation signatures in human cancers, particularly those derived from non-hematopoietic tissues. In sharp contrast, the generally low CNV burden in leukemia leaves the CNV landscape and variations largely unexplored, impeding understanding of CNV in leukemia development. Through a comprehensive compilation of public datasets, we constructed LeukAtlas ( https://ngdc.cncb.ac.cn/leukemia ), a user-friendly database encompassing 12,597 CNVs from 1446 AML samples across diverse subtypes and age groups, providing tools for multidimensional CNV analysis. Our analyses suggested the CNV levels significantly varied among AML patients. We discovered two previously unknown CNV patterns in adult AML patients, dominated by segmental LOH and/or minor gain, which have been shown to be associated with chromosomal instability in solid tumors. Additionally, we defined two potential new AML subgroups based on CNVs status, providing new stratification markers within the existing karyotype framework. Representing the most extensive CNV collection in AML, LeukAtlas is a valuable resource for exploring the role of CNVs in the pathogenesis and prognosis stratification of leukemia. Interrogation of this database uncovers novel subclasses with unique CNV profiles and reveals heterogeneous CNV patterns in AML, demonstrating the potential role of chromosomal instability in AML progression.
Indexed as
Identifiers
39894867What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.